Enjamb Labs
Where drug teams run their entire program, discovery to FDA approval
Enjamb Labs is a business in b2b based in San Francisco, CA, USA.
Profile
Enjamb runs the entire drug program for biopharma teams, from discovery to FDA approval. Pharma runs on decades of closed legacy systems like Benchling, Veeva, Medidata, and SAS, with no AI layer and no MCP to connect agents to them.
So we built that connection layer in one platform. Our agents run on top of their existing systems and data, with no migration, and do the work across the whole program: clinical evidence, trial design, statistical programming, and regulatory submissions.
In just 3 weeks since launch, we're already being used by 500+ employees at top pharma companies, including Johnson & Johnson, AbbVie, Bristol Myers Squibb, Merck & Sanofi.
Within the b2b space, the company focuses on its core offering rather than a broad product line.
The business is associated with San Francisco, CA, USA.
It is recorded at the Spring 2026 stage.
Recorded headcount: 2 employees.
Directory analysis
Enjamb Labs offers an integrated platform that connects to legacy biopharma systems, enabling AI‑driven automation across the entire drug development lifecycle from discovery to FDA approval. The platform embeds agents that handle clinical evidence, trial design, statistical programming, and regulatory submissions without requiring data migration. Since launch, it has been adopted by employees at major pharma companies such as Johnson & Johnson, AbbVie, and others.
Positioning: Enjamb Labs positions itself as a comprehensive solution that bridges entrenched biopharma workflows with AI capabilities, targeting large pharmaceutical organizations. Its early adoption by key industry players indicates market traction, though the company remains in a very early stage with a small team.
Note: Enjamb Labs provides AI agents that integrate with existing pharma platforms to automate drug development tasks.
Auto-generated directory analysis from public data · updated 6 Oct 2026. Informational only, not investment advice.
| Sector | B2B |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Spring 2026 |
Website: www.enjamb.ai
Browse related
Create a free account